Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions

Gilead will pay $202 million to settle charges of paying kickbacks to docs for boosting HIV drug sales

Gilead Sciences agreed to pay $202 million to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines, the latest example of a controversial practice that has come back to haunt numerous drugmakers over the years. From 2011 through 2017, Gilead held more than 17,300 speaker programs of which 9,500 were dinners to promote sales of HIV drugs that were supposed to be educational. But the dinners we…

Gilead Sciences Agrees to Pay $202 Million Over Doctor Payments

Gilead Sciences Inc. reached a $202 settlement with the US to resolve claims that it paid doctors and gave them meals and travel expenses for events to get them to prescribe its drugs.

Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions

The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved Monday.

Gilead forks out $200m settlement after kickbacks to doctors - Juta MedicalBrief

Pharmaceutical company Gilead Sciences has settled a massive civil lawsuit and admitted to paying hundreds of thousands of dollars and kickbacks in the form of honoraria payments, meals, and travel expenses to healthcare practitioners who spoke at or attended Gilead speaker events to induce them to prescribe its HIV drugs. Under the settlement approved last […]

Gilead Sciences reported this Thursday that it has developed an innovative Vih risk prediction model that identifies people at high risk of having Vih (calibrating the individual risk of each of them), thanks to a screening strategy directed in a given area, thus reducing the late diagnosis and avoiding new infections. Analyzing only information about certain diseases diagnosed prior to a person, age and sex at birth, the model has demonstrated …

Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors - Regional Media News

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying kickbacks to doctors who agreed to prescribe its HIV drugs, the U.S. attorney’s office in Manhattan said on Tuesday. The settlement resolves claims that Gilead paid honoraria, meals and travel expenses to doctors who attended Gilead speaker events to induce them to prescribe several HIV drugs. U.S. Attorney Ja…